NO20040768L - Fremgangsmate for rensing av glykopeptidfosfonatderivater. - Google Patents

Fremgangsmate for rensing av glykopeptidfosfonatderivater.

Info

Publication number: NO20040768L
Authority: NO; Norway
Prior art keywords: purification; glycopeptide; phosphonate derivatives; glycopeptide phosphonate; derivatives
Prior art date: 2001-08-24

Application number

NO20040768A

Other languages

English (en)

Other versions

NO330734B1 (no

Inventor

Jr Donal Schmidt

Jeanmarie Donovan Sganga

Original Assignee

Theravance Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-08-24

Filing date

2004-02-20

Publication date

2004-04-29

2004-02-20 Application filed by Theravance Inc filed Critical Theravance Inc

2004-04-29 Publication of NO20040768L publication Critical patent/NO20040768L/no

2011-06-27 Publication of NO330734B1 publication Critical patent/NO330734B1/no

Links

238000000034 method Methods 0.000 title abstract 3
102000002068 Glycopeptides Human genes 0.000 title abstract 2
108010015899 Glycopeptides Proteins 0.000 title abstract 2
-1 glycopeptide phosphonate derivatives Chemical class 0.000 title 1
238000000746 purification Methods 0.000 title 1
DQJCDTNMLBYVAY-ZXXIYAEKSA-N (2S,5R,10R,13R)-16-{[(2R,3S,4R,5R)-3-{[(2S,3R,4R,5S,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-5-(ethylamino)-6-hydroxy-2-(hydroxymethyl)oxan-4-yl]oxy}-5-(4-aminobutyl)-10-carbamoyl-2,13-dimethyl-4,7,12,15-tetraoxo-3,6,11,14-tetraazaheptadecan-1-oic acid Chemical class NCCCC[C@H](C(=O)N[C@@H](C)C(O)=O)NC(=O)CC[C@H](C(N)=O)NC(=O)[C@@H](C)NC(=O)C(C)O[C@@H]1[C@@H](NCC)C(O)O[C@H](CO)[C@H]1O[C@H]1[C@H](NC(C)=O)[C@@H](O)[C@H](O)[C@@H](CO)O1 DQJCDTNMLBYVAY-ZXXIYAEKSA-N 0.000 abstract 2
239000011347 resin Substances 0.000 abstract 2
229920005989 resin Polymers 0.000 abstract 2
239000004793 Polystyrene Substances 0.000 abstract 1
239000003242 anti bacterial agent Substances 0.000 abstract 1
239000007864 aqueous solution Substances 0.000 abstract 1
125000001476 phosphono group Chemical group [H]OP(*)(=O)O[H] 0.000 abstract 1
229920002223 polystyrene Polymers 0.000 abstract 1
239000000243 solution Substances 0.000 abstract 1
125000001424 substituent group Chemical group 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
- C07K9/006—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence being part of a ring structure
- C07K9/008—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence being part of a ring structure directly attached to a hetero atom of the saccharide radical, e.g. actaplanin, avoparcin, ristomycin, vancomycin

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Biochemistry (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Molecular Biology (AREA)
Genetics & Genomics (AREA)
Biophysics (AREA)
Pharmacology & Pharmacy (AREA)
Communicable Diseases (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
Oncology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Analytical Chemistry (AREA)
Peptides Or Proteins (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

NO20040768A 2001-08-24 2004-02-20 Fremgangsmåte for rensing av glykopeptidfosfonatderivater. NO330734B1 (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US31471201P	2001-08-24	2001-08-24
PCT/US2002/026854 WO2003018608A2 (en)	2001-08-24	2002-08-23	Process for purifying glycopeptide phosphonate derivatives

Publications (2)

Publication Number	Publication Date
NO20040768L true NO20040768L (no)	2004-04-29
NO330734B1 NO330734B1 (no)	2011-06-27

Family

ID=23221118

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20040768A NO330734B1 (no)	2001-08-24	2004-02-20	Fremgangsmåte for rensing av glykopeptidfosfonatderivater.

Country Status (14)

Country	Link
US (5)	US7015307B2 (no)
EP (1)	EP1487863B1 (no)
JP (1)	JP4116547B2 (no)
KR (1)	KR100905009B1 (no)
CN (1)	CN100418980C (no)
AT (1)	ATE430159T1 (no)
AU (1)	AU2002326740A1 (no)
CA (1)	CA2457218C (no)
DE (1)	DE60232197D1 (no)
DK (1)	DK1487863T3 (no)
ES (1)	ES2324771T3 (no)
NO (1)	NO330734B1 (no)
TW (1)	TWI233932B (no)
WO (1)	WO2003018608A2 (no)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
UA75083C2 (uk) *	2000-06-22	2006-03-15	Тераванс, Інк.	Похідні глікопептидфосфонатів
TWI233932B (en) *	2001-08-24	2005-06-11	Theravance Inc	Process for purifying glycopeptide phosphonate derivatives
TWI342312B (en) *	2003-10-22	2011-05-21	Theravance Inc	Hydrochloride salts of a glycopeptide phosphonate derivative
AU2005308160A1 (en)	2004-11-29	2006-06-01	National University Corporation Nagoya University	Glycopeptide antibiotic monomer derivatives
TW200808818A (en) *	2006-05-26	2008-02-16	Shionogi & Co	Glycopeptide antibiotic derivatives
US20090069219A1 (en) *	2007-09-09	2009-03-12	Protia, Llc	Deuterium-enriched telavancin
EP2238102A4 (en) *	2007-12-26	2011-03-09	Lead Therapeutics Inc	NEW HALF-SYNTHETIC GLYCOPEPTIDES AS ANTIBACTERIAL AGENTS
GB2465863A (en) *	2008-12-05	2010-06-09	Lead Therapeutics Inc	Semi-synthetic heptapeptidic glycopeptides for the treatment of bacterial infections
CN103105327A (zh) *	2011-11-11	2013-05-15	中国科学院大连化学物理研究所	采用金属氧化物富集糖肽的通用方法
US9753436B2 (en)	2013-06-11	2017-09-05	Apple Inc.	Rotary input mechanism for an electronic device
KR102231031B1 (ko)	2013-08-09	2021-03-23	애플 인크.	전자 디바이스용 촉각 스위치
CN107759672A (zh)	2013-08-19	2018-03-06	南京爱斯药业有限公司	万古霉素衍生物、制备方法及其应用
US10048802B2 (en)	2014-02-12	2018-08-14	Apple Inc.	Rejection of false turns of rotary inputs for electronic devices
US10190891B1 (en)	2014-07-16	2019-01-29	Apple Inc.	Optical encoder for detecting rotational and axial movement
KR102544557B1 (ko)	2014-09-02	2023-06-20	애플 인크.	웨어러블 전자 디바이스
WO2016137806A2 (en)	2015-02-23	2016-09-01	Theravance Biopharma Antibiotics Ip, Llc	Doses and methods of administering telavancin
CN105985412A (zh) *	2015-02-28	2016-10-05	爱斯医药科技(南京)有限公司	万古霉素衍生物、制备方法及其应用
JP6515185B2 (ja)	2015-03-05	2019-05-15	アップルインコーポレイテッドＡｐｐｌｅＩｎｃ．	方向依存光学特性を有する光学エンコーダを有する時計、手首装着型電子デバイス及びウェラブル電子デバイス
WO2016144919A1 (en)	2015-03-08	2016-09-15	Apple Inc.	Compressible seal for rotatable and translatable input mechanisms
US10018966B2 (en)	2015-04-24	2018-07-10	Apple Inc.	Cover member for an input mechanism of an electronic device
US9891651B2 (en)	2016-02-27	2018-02-13	Apple Inc.	Rotatable input mechanism having adjustable output
CN107325159A (zh) *	2016-04-29	2017-11-07	中国科学院上海药物研究所	一类万古霉素衍生物、其制备方法、药物组合物和用途
US10551798B1 (en)	2016-05-17	2020-02-04	Apple Inc.	Rotatable crown for an electronic device
US10061399B2 (en)	2016-07-15	2018-08-28	Apple Inc.	Capacitive gap sensor ring for an input device
US10019097B2 (en)	2016-07-25	2018-07-10	Apple Inc.	Force-detecting input structure
US10664074B2 (en)	2017-06-19	2020-05-26	Apple Inc.	Contact-sensitive crown for an electronic watch
US10962935B1 (en)	2017-07-18	2021-03-30	Apple Inc.	Tri-axis force sensor
US11360440B2 (en)	2018-06-25	2022-06-14	Apple Inc.	Crown for an electronic watch
US11561515B2 (en)	2018-08-02	2023-01-24	Apple Inc.	Crown for an electronic watch
US12259690B2 (en)	2018-08-24	2025-03-25	Apple Inc.	Watch crown having a conductive surface
CN209560398U (zh)	2018-08-24	2019-10-29	苹果公司	电子表
US11181863B2 (en)	2018-08-24	2021-11-23	Apple Inc.	Conductive cap for watch crown
US11194298B2 (en)	2018-08-30	2021-12-07	Apple Inc.	Crown assembly for an electronic watch
CN209625187U (zh)	2018-08-30	2019-11-12	苹果公司	电子手表和电子设备
US11194299B1 (en)	2019-02-12	2021-12-07	Apple Inc.	Variable frictional feedback device for a digital crown of an electronic watch
US11550268B2 (en)	2020-06-02	2023-01-10	Apple Inc.	Switch module for electronic crown assembly
US11635786B2 (en)	2020-06-11	2023-04-25	Apple Inc.	Electronic optical sensing device
US12092996B2 (en)	2021-07-16	2024-09-17	Apple Inc.	Laser-based rotation sensor for a crown of an electronic watch
US12189347B2 (en)	2022-06-14	2025-01-07	Apple Inc.	Rotation sensor for a crown of an electronic watch

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4440753A (en) *	1982-03-15	1984-04-03	Eli Lilly And Company	Purification of glycopeptide antibiotics using non-functional resins
US4667024A (en) *	1983-07-13	1987-05-19	Smithkline Beckman Corporation	Process for the preparation of purified vancomycin class antibiotics
GB8608798D0 (en) *	1986-04-11	1986-05-14	Lepetit Spa	Recovery of glycopeptide antibiotics from aqueous solutions
US4845104A (en) *	1986-11-20	1989-07-04	Merck & Co., Inc.	Oxidized analogs of 17β-N-monosubstituted-carbamoyl-4-aza-5-α-androstan-3-ones
US4845194A (en) *	1987-02-27	1989-07-04	Eli Lilly And Company	Glycopeptide recovery process
US4874843A (en) *	1987-12-03	1989-10-17	Eli Lilly And Company	Chromatographic purification process
US4996148A (en) *	1987-07-13	1991-02-26	Eli Lilly And Company	A80407 antibiotics
JP2577133B2 (ja)	1989-11-27	1997-01-29	スティフティングフォールドテフニスヘウェッテンスハッペン	船舶のプロペラ
US5258495A (en) *	1990-07-10	1993-11-02	Abbott Laboratories	Process for making vancomycin HC1
US5149784A (en) *	1990-07-10	1992-09-22	Abbott Laboratories	Process for making vancomycin
DE4039451A1 (de) *	1990-12-11	1992-06-17	Hoechst Ag	Metallocene mit bicyclischen cyclopentadienderivaten als liganden, verfahren zu ihrer herstellung und ihre verwendung als katalysatoren
AU670081B2 (en)	1992-04-20	1996-07-04	Abbott Laboratories	Process for making vancomycin
AU703106B2 (en) *	1994-01-28	1999-03-18	Eli Lilly And Company	Glycopeptide antibiotic derivatives
SI9500039B (sl) *	1995-02-07	2002-02-28	Lek,	Nov kombiniran postopek čiščenja Vankomicin hidroklorida
WO1998026085A1 (fr)	1996-12-11	1998-06-18	Nippon Kayaku Kabushiki Kaisha	Procedes de fabrication de vancomycine
UA75083C2 (uk)	2000-06-22	2006-03-15	Тераванс, Інк.	Похідні глікопептидфосфонатів
TWI233932B (en) *	2001-08-24	2005-06-11	Theravance Inc	Process for purifying glycopeptide phosphonate derivatives

2002
- 2002-08-20 TW TW091118800A patent/TWI233932B/zh not_active IP Right Cessation
- 2002-08-23 CN CNB028166159A patent/CN100418980C/zh not_active Expired - Fee Related
- 2002-08-23 ES ES02761476T patent/ES2324771T3/es not_active Expired - Lifetime
- 2002-08-23 EP EP02761476A patent/EP1487863B1/en not_active Expired - Lifetime
- 2002-08-23 JP JP2003523267A patent/JP4116547B2/ja not_active Expired - Fee Related
- 2002-08-23 WO PCT/US2002/026854 patent/WO2003018608A2/en not_active Ceased
- 2002-08-23 AT AT02761476T patent/ATE430159T1/de not_active IP Right Cessation
- 2002-08-23 DK DK02761476T patent/DK1487863T3/da active
- 2002-08-23 US US10/226,676 patent/US7015307B2/en not_active Expired - Lifetime
- 2002-08-23 CA CA2457218A patent/CA2457218C/en not_active Expired - Fee Related
- 2002-08-23 AU AU2002326740A patent/AU2002326740A1/en not_active Abandoned
- 2002-08-23 KR KR1020047002618A patent/KR100905009B1/ko not_active Expired - Fee Related
- 2002-08-23 DE DE60232197T patent/DE60232197D1/de not_active Expired - Lifetime
2004
- 2004-02-20 NO NO20040768A patent/NO330734B1/no not_active IP Right Cessation
2005
- 2005-12-13 US US11/301,740 patent/US7375181B2/en not_active Expired - Lifetime
2007
- 2007-10-25 US US11/977,605 patent/US7468420B2/en not_active Expired - Lifetime
2008
- 2008-11-17 US US12/272,554 patent/US7858583B2/en not_active Expired - Fee Related
2010
- 2010-11-16 US US12/947,686 patent/US20110257364A1/en not_active Abandoned

Also Published As

Publication number	Publication date
NO330734B1 (no)	2011-06-27
CA2457218C (en)	2011-08-02
EP1487863B1 (en)	2009-04-29
JP4116547B2 (ja)	2008-07-09
DK1487863T3 (da)	2009-07-13
US20060100415A1 (en)	2006-05-11
EP1487863A4 (en)	2007-08-29
DE60232197D1 (de)	2009-06-10
WO2003018608A3 (en)	2004-10-07
US7375181B2 (en)	2008-05-20
WO2003018608A8 (en)	2003-04-24
CN1671732A (zh)	2005-09-21
US7858583B2 (en)	2010-12-28
TWI233932B (en)	2005-06-11
US7015307B2 (en)	2006-03-21
US20090215673A1 (en)	2009-08-27
ES2324771T3 (es)	2009-08-14
JP2005505542A (ja)	2005-02-24
CN100418980C (zh)	2008-09-17
US20080103290A1 (en)	2008-05-01
US20110257364A1 (en)	2011-10-20
WO2003018608A2 (en)	2003-03-06
CA2457218A1 (en)	2003-03-06
KR20040028998A (ko)	2004-04-03
US7468420B2 (en)	2008-12-23
EP1487863A2 (en)	2004-12-22
KR100905009B1 (ko)	2009-06-29
AU2002326740A1 (en)	2003-03-10
US20030119722A1 (en)	2003-06-26
ATE430159T1 (de)	2009-05-15

Publication	Publication Date	Title
NO20040768L (no)	2004-04-29	Fremgangsmate for rensing av glykopeptidfosfonatderivater.
IS6600A (is)	2002-10-29	Glýkópeptíð fosfónatafleiður
MX9304647A (es)	1994-02-28	7-(sustituido)-9-[(glicilo sustituido)amido]-6-desmetil-6-desoxitetraciclinas y metodo para su produccion.
ATE322681T1 (de)	2006-04-15	Inhibitoren für wachstumdifferenzierungsfaktor und ihre anwendungen
ATE310009T1 (de)	2005-12-15	Reaktionssysteme zur herstellung von n- (phosphonomethyl)glyzin verbindungen
MXPA04002067A (es)	2004-06-07	Nuevas dihidropteridinonas, procedimientos para su preparacion y su uso como medicamento.
FR2857361B1 (fr)	2005-09-09	PREPARATION DE DERIVES DE 1,3-DIPHENYPROP-2-¼n-1-one
GT200000103A (es)	2001-12-20	Trifluorbutenos nematocidas.
BRPI0414598A (pt)	2006-11-07	indóis substituìdos
ATE201203T1 (de)	2001-06-15	Chirale methylphenyloxazolidinone
NO20050091L (no)	2005-04-06	Fremgangsmater for fremstilling av fibrinogen
YU63696A (sh)	1999-07-28	Novi fenilamidin-derivati, postupci za njihovo pripremanje i njihova primena kao lekova
MXPA04001855A (es)	2004-06-15	Derivados de sistemas de indan-1-ol c2-sustituidos, metodos para la produccion de los mismos y su uso como medicamentos.
DE50203388D1 (de)	2005-07-14	Verbessertes verfahren zur herstellung von bisphosphiten
MXPA04001849A (es)	2004-06-15	Sistemas de indan-1-ol c2-disustituidos, metodo para su produccion y su uso como medicamentos.
MXPA04001854A (es)	2004-06-15	Sistema de indan-1-ol polisubstituidos, metodo para la produccion y uso de los mismos como drogas.
FI20001807A0 (fi)	2000-08-15	Menetelmä proteiinipitoisen kuidun käsittelemiseksi
TH77750A (th)	2006-06-01	อนุพันธ์ไกลโคเปปไทด์ฟอสโฟเนท

Legal Events

Date	Code	Title	Description
2015-11-09	CHAD	Change of the owner's name or address (par. 44 patent law, par. patentforskriften)	Owner name: THERAVANCE BIOPHARMA R&D IP, US
2015-11-16	CHAD	Change of the owner's name or address (par. 44 patent law, par. patentforskriften)	Owner name: THERAVANCE BIOPHARMA ANTIBIOTICS IP, US
2019-04-15	CHAD	Change of the owner's name or address (par. 44 patent law, par. patentforskriften)	Owner name: CUMBERLAND PHARMACEUTICALS INC., US
2020-03-23	MM1K	Lapsed by not paying the annual fees